Germany· DE-A57-9965abfd92a37848
Syner-Kinase
A medicinal product containing urokinase, registered in Germany by Syner-Medica B.V..
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Urokinase
- Manufacturer
- Syner-Medica B.V.
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- August 5, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Urokinase in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomSyner-KINASE 10,000unit powder for solution for injection vialsSyner-Med (Pharmaceutical Products) Ltd
- NetherlandsUrokinase Pharma-Zentrale 10.000 IE, poeder voor oplossing voor intraveneuze infusiePharma-Zentrale GmbH
- BelgiumActosolv 100000 IUEumedica Pharmaceuticals
- SpainUROKINASE TEOFARMA 100.000 UI. POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSIONTeofarma S.R.L.
- FranceACTOSOLV 100 000 UI, poudre pour solution injectable/pour perfusionEUMEDICA PHARMACEUTICALS (ALLEMAGNE)
- PolandUrokinase medacPharma-Zentrale GmbH
- FinlandUrokinase MedacMedac Gesellschaft Für Klinische Spezialpräparate mbH
- Japanウロキナーゼ持田製薬
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Austria · Urokinase Medac
- Belgium · Actosolv, Urokinase Syner-Medica
- Spain · Urokinase Teofarma, Uroquinasa Syner Medica
- France · Actosolv, Therasolv
- United Kingdom (Northern Ireland) · Syner-Kinase
- Italy · Urochinasi Eg, Urokinasi Pfizer
- Luxembourg · Actosolv
- Netherlands · Urokinase Devrimed, Urokinase Pharma-Zentrale
- Poland · Urokinase Medac
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fc0df407-3f2c-402f-bd68-7c8c7ae711f9 GET /v1/drugs/fc0df407-3f2c-402f-bd68-7c8c7ae711f9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intraarterial Use, Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Urokinase",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about urokinase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.